{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:25:39Z","timestamp":1790760339710,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T00:00:00Z","timestamp":1437609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T00:00:00Z","timestamp":1437609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Protoc"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/nprot.2015.080","type":"journal-article","created":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T15:22:44Z","timestamp":1437664964000},"page":"1264-1274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis"],"prefix":"10.1038","volume":"10","author":[{"given":"Thomas","family":"Reiberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunching","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh R","family":"Ramjiawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai","family":"Hato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Roberge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peigen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y","family":"Lauwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew X","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeel","family":"Bardeesy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh K","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan G","family":"Duda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,23]]},"reference":[{"key":"BFnprot2015080_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/hep.27388","volume":"61","author":"B Njei","year":"2015","unstructured":"Njei, B., Rotman, Y., Ditah, I. & Lim, J.K. Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology 61, 191\u2013199 (2015).","journal-title":"Hepatology"},{"key":"BFnprot2015080_CR2","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S1470-2045(12)70271-1","volume":"13","author":"A Forner","year":"2012","unstructured":"Forner, A. & Bruix, J. Biomarkers for early diagnosis of hepatocellular carcinoma. Lancet Oncol. 13, 750\u2013751 (2012).","journal-title":"Lancet Oncol."},{"key":"BFnprot2015080_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrclinonc.2011.30","volume":"8","author":"AX Zhu","year":"2011","unstructured":"Zhu, A.X., Duda, D.G., Sahani, D.V. & Jain, R.K. HCC and angiogenesis: possible targets and future directions. Nat. Rev. Clin. Oncol. 8, 292\u2013301 (2011).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"BFnprot2015080_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1053\/j.gastro.2013.01.002","volume":"144","author":"V Hernandez-Gea","year":"2013","unstructured":"Hernandez-Gea, V., Toffanin, S., Friedman, S.L. & Llovet, J.M. Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. Gastroenterology 144, 512\u2013527 (2013).","journal-title":"Gastroenterology"},{"key":"BFnprot2015080_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1146\/annurev-chembioeng-061010-114300","volume":"2","author":"VP Chauhan","year":"2011","unstructured":"Chauhan, V.P., Stylianopoulos, T., Boucher, Y. & Jain, R.K. Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. Annu. Rev. Chem. Biomol. Eng. 2, 281\u2013298 (2011).","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"BFnprot2015080_CR6","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3748\/wjg.v20.i3.786","volume":"20","author":"AL Inghilesi","year":"2014","unstructured":"Inghilesi, A.L. et al. Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib. World J. Gastroenterol. 20, 786\u2013794 (2014).","journal-title":"World J. Gastroenterol."},{"key":"BFnprot2015080_CR7","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/hep.26790","volume":"59","author":"Y Chen","year":"2014","unstructured":"Chen, Y. et al. Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 \u03b1\/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice. Hepatology 59, 1435\u20131447 (2014).","journal-title":"Hepatology"},{"key":"BFnprot2015080_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1055\/s-0030-1247133","volume":"30","author":"A Forner","year":"2010","unstructured":"Forner, A., Reig, M.E., de Lope, C.R. & Bruix, J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin. Liver Dis. 30, 61\u201374 (2010).","journal-title":"Semin. Liver Dis."},{"key":"BFnprot2015080_CR9","doi-asserted-by":"crossref","unstructured":"European Association For The Study Of The Liver. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J. Hepatol. 56, 908\u2013943 (2012).","DOI":"10.1016\/j.jhep.2011.12.001"},{"key":"BFnprot2015080_CR10","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/jcb.21187","volume":"101","author":"D Fukumura","year":"2007","unstructured":"Fukumura, D. & Jain, R.K. Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J. Cell. Biochem. 101, 937\u2013949 (2007).","journal-title":"J. Cell. Biochem."},{"key":"BFnprot2015080_CR11","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/hep.27665","volume":"61","author":"Y Chen","year":"2015","unstructured":"Chen, Y. et al. CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice. Hepatology 61, 1591\u20131602 (2015).","journal-title":"Hepatology"},{"key":"BFnprot2015080_CR12","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jhep.2008.01.008","volume":"48","author":"P Newell","year":"2008","unstructured":"Newell, P., Villanueva, A., Friedman, S.L., Koike, K. & Llovet, J.M. Experimental models of hepatocellular carcinoma. J. Hepatol. 48, 858\u2013879 (2008).","journal-title":"J. Hepatol."},{"key":"BFnprot2015080_CR13","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1158\/1078-0432.CCR-05-2568","volume":"12","author":"H Huynh","year":"2006","unstructured":"Huynh, H., Soo, K.C., Chow, P.K., Panasci, L. & Tran, E. Xenografts of human hepatocellular carcinoma: a useful model for testing drugs. Clin. Cancer Res. 12, 4306\u20134314 (2006).","journal-title":"Clin. Cancer Res."},{"key":"BFnprot2015080_CR14","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/hep.21293","volume":"44","author":"C Coulouarn","year":"2006","unstructured":"Coulouarn, C. et al. Oncogene-specific gene expression signatures at preneoplastic stage in mice define distinct mechanisms of hepatocarcinogenesis. Hepatology 44, 1003\u20131011 (2006).","journal-title":"Hepatology"},{"key":"BFnprot2015080_CR15","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1002\/hep.25868","volume":"56","author":"J Srivastava","year":"2012","unstructured":"Srivastava, J. et al. Astrocyte elevated gene-1 promotes hepatocarcinogenesis: novel insights from a mouse model. Hepatology 56, 1782\u20131791 (2012).","journal-title":"Hepatology"},{"key":"BFnprot2015080_CR16","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/hep.27339","volume":"61","author":"J Srivastava","year":"2015","unstructured":"Srivastava, J. et al. Astrocyte elevated gene-1 and c-Myc cooperate to promote hepatocarcinogenesis in mice. Hepatology 61, 915\u2013929 (2015).","journal-title":"Hepatology"},{"key":"BFnprot2015080_CR17","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1158\/0008-5472.CAN-10-2705","volume":"71","author":"JK Stauffer","year":"2011","unstructured":"Stauffer, J.K. et al. Coactivation of AKT and \u03b2-catenin in mice rapidly induces formation of lipogenic liver tumors. Cancer Res. 71, 2718\u20132727 (2011).","journal-title":"Cancer Res."},{"key":"BFnprot2015080_CR18","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1172\/JCI64742","volume":"123","author":"G Willimsky","year":"2013","unstructured":"Willimsky, G., Schmidt, K., Loddenkemper, C., Gellermann, J. & Blankenstein, T. Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance. J. Clin. Invest. 123, 1032\u20131043 (2013).","journal-title":"J. Clin. Invest."},{"key":"BFnprot2015080_CR19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","volume":"26","author":"MJ Wolf","year":"2014","unstructured":"Wolf, M.J. et al. Metabolic activation of intrahepatic CD8+ T cells and NK T cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell 26, 549\u2013564 (2014).","journal-title":"Cancer Cell"},{"key":"BFnprot2015080_CR20","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2009.09.026","volume":"16","author":"D Zhou","year":"2009","unstructured":"Zhou, D. et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 16, 425\u2013438 (2009).","journal-title":"Cancer Cell"},{"key":"BFnprot2015080_CR21","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.cell.2006.05.030","volume":"125","author":"L Zender","year":"2006","unstructured":"Zender, L. et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125, 1253\u20131267 (2006).","journal-title":"Cell"},{"key":"BFnprot2015080_CR22","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/onc.2010.504","volume":"30","author":"MZ Xu","year":"2011","unstructured":"Xu, M.Z. et al. AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Oncogene 30, 1229\u20131240 (2011).","journal-title":"Oncogene"},{"key":"BFnprot2015080_CR23","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1002\/hep.27246","volume":"60","author":"T Hato","year":"2014","unstructured":"Hato, T., Goyal, L., Greten, T.F., Duda, D.G. & Zhu, A.X. Immune checkpoint blockade in hepatocellular carcinoma: current progress and future directions. Hepatology 60, 1776\u20131782 (2014).","journal-title":"Hepatology"},{"key":"BFnprot2015080_CR24","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jhep.2012.06.011","volume":"57","author":"HL Zhang","year":"2012","unstructured":"Zhang, H.L. et al. Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats. J. Hepatol. 57, 803\u2013812 (2012).","journal-title":"J. Hepatol."},{"key":"BFnprot2015080_CR25","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1053\/j.gastro.2013.11.008","volume":"146","author":"H Yin","year":"2014","unstructured":"Yin, H. et al. Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver. Gastroenterology 146, 801\u2013811 (2014).","journal-title":"Gastroenterology"},{"key":"BFnprot2015080_CR26","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1073\/pnas.0911427107","volume":"107","author":"L Lu","year":"2010","unstructured":"Lu, L. et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc. Natl. Acad. Sci. USA 107, 1437\u20131442 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnprot2015080_CR27","unstructured":"Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals http:\/\/www.nap.edu\/catalog\/12910\/guide-for-the-care-and-use-of-laboratory-animals-eighth (National Academies Press, 2011)."},{"key":"BFnprot2015080_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/hep.1840200104","volume":"20","author":"The French METAVIR Cooperative Stud","year":"1994","unstructured":"The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20, 15\u201320 (1994).","journal-title":"Hepatology"},{"key":"BFnprot2015080_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jss.2008.08.036","volume":"155","author":"KH Lee","year":"2009","unstructured":"Lee, K.H. et al. Percutaneous US-guided implantation of Vx-2 carcinoma into rabbit liver: a comparison with open surgical method. J. Surg. Res. 155, 94\u201399 (2009).","journal-title":"J. Surg. Res."},{"key":"BFnprot2015080_CR30","doi-asserted-by":"publisher","first-page":"20507","DOI":"10.1073\/pnas.0710528105","volume":"104","author":"KD Bissig","year":"2007","unstructured":"Bissig, K.D., Le, T.T., Woods, N.B. & Verma, I.M. Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model. Proc. Natl. Acad. Sci. USA 104, 20507\u201320511 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnprot2015080_CR31","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.biotechadv.2011.08.021","volume":"29","author":"BA Tannous","year":"2011","unstructured":"Tannous, B.A. & Teng, J. Secreted blood reporters: insights and applications. Biotechnol. Adv. 29, 997\u20131003 (2011).","journal-title":"Biotechnol. Adv."}],"container-title":["Nature Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nprot.2015.080.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nprot.2015.080","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nprot.2015.080.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T08:12:18Z","timestamp":1630051938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nprot.2015.080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,23]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["BFnprot2015080"],"URL":"https:\/\/doi.org\/10.1038\/nprot.2015.080","relation":{},"ISSN":["1754-2189","1750-2799"],"issn-type":[{"value":"1754-2189","type":"print"},{"value":"1750-2799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,23]]},"assertion":[{"value":"23 July 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}